Clinical Trial

Ketamine Added to Quadratus Lumborum Block for Pain Relief After Infant Pyeloplasty

Study acronym: KETA-QLB
Completed Phase 4
View on ClinicalTrials.gov →
Summary
This prospective randomized study evaluates the effect of adding ketamine to bupivacaine in ultrasound-guided quadratus lumborum (QL) block for postoperative pain management in infants undergoing open pyeloplasty. Forty infants aged 0-12 months undergoing elective open pyeloplasty are randomly assigned to receive either QL block with bupivacaine plus ketamine or QL block with bupivacaine alone. Postoperative pain is assessed using the CRIES pain scale. Additional outcomes include duration of analgesia, rescue opioid requirements, total opioid consumption, length of hospital stay, and occurrence of complications.
Trial Details
NCT Number NCT07596810
Lead Sponsor Alexandria University
Conditions Ureteropelvic Junction Obstruction, Postoperative Pain
Enrollment 40 participants
Start Date 2025-06-01
Primary Completion 2026-01-01 (estimated)
Study Completion 2026-02-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-19